Author:
Wood Adam,Breffa Catherine,Chaine Caroline,Cubberley Richard,Dent Matthew,Eichhorn Joachim,Fayyaz Susann,Grimm Fabian A.,Houghton Jade,Kiwamoto Reiko,Kukic Predrag,Lee MoungSook,Malcomber Sophie,Martin Suzanne,Nicol Beate,Reynolds Joe,Riley Gordon,Scott Sharon,Smith Colin,Westmoreland Carl,Wieland Willemien,Williams Mesha,Wolton Kathryn,Zellmann Tristan,Gutsell Steve
Reference72 articles.
1. A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic Products;Baltazar;Toxicol. Sci.,2020
2. Implementing in vitro bioactivity data to modernize priority setting of chemical inventories;Beal;ALTEX - Altern. Anim. Exp.,2022
3. Fate and exposure modeling in regulatory chemical evaluation: new directions from retrospection [10.1039/C7EM00510E];Bonnell;Environ. Sci.: Process. Impacts,2018
4. Analysis of health concerns not addressed by REACH for low tonnage chemicals and opportunities for new approach methodology;Botham;Arch. Toxicol.,2023
5. Reducing safety-related drug attrition: the use of in vitro pharmacological profiling;Bowes;Nat. Rev. Drug Discov.,2012